Kang M, Mackay L, Christie D, Callon C, Argento E Can psychedelic-assisted psychotherapy play a role in enhancing motivation to change in addiction treatment settings? J Psychedelic Stud Link

Argento E, Socías ME, Hayashi K, Choi JC, Mackay L, Christie D, Milloy MJ, DeBeck K Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting Int J Drug Policy PubMed

Argento E, Christie D, Mackay L, Callon C, Walsh Z Psychedelic-assisted psychotherapy after COVID-19: the therapeutic uses of psilocybin and MDMA for pandemic-related mental health problems Front Psychiatry PubMed

Mackay L, Bach P, Milloy MJ, Cui Z, Kerr T, Hayashi K The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs Drug Alcohol Depend PubMed

Mackay L, Kerr T, Fairbairn N, Grant C, Milloy MJ, Hayashi K The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting Addict Sci Clin Pract PubMed

Mackay L, Ickowicz S, Hayashi K, Abrahams R Rooming-in and loss of child custody: key factors in maternal overdose risk Addiction PubMed